Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionLVW Advisors, LLC
Latest Disclosed Ownership23,548 shares
Latest Disclosed Value $ 3,281,885
LVW Advisors, LLC reports 7.91% increase in ownership of GILD / Gilead Sciences, Inc.

On April 20, 2026 - LVW Advisors, LLC filed a 13F-HR form disclosing ownership of 23,548 shares of Gilead Sciences, Inc. (CH:GILD) valued at $3,281,885 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 14, 2026 disclosing 21,821 shares of Gilead Sciences, Inc.. This represents a change in shares of 7.91% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-20 2026-03-31 13F GILEAD SCIENCES COM 375558103 23,548 1,727 7.91 3,282 22.52 0.3127
2026-01-14 2025-12-31 13F GILEAD SCIENCES COM 375558103 21,821 1,872 9.38 2,678 20.96 0.2715
2025-10-20 2025-09-30 13F GILEAD SCIENCES COM 375558103 19,949 271 1.38 2,214 1.51 0.2261
2025-07-17 2025-06-30 13F GILEAD SCIENCES COM 375558103 19,678 1,338 7.30 2,182 6.18 0.2380
2025-04-09 2025-03-31 13F GILEAD SCIENCES COM 375558103 18,340 -483 -2.57 2,055 18.18 0.2457
2025-01-16 2024-12-31 13F GILEAD SCIENCES COM 375558103 18,823 4 0.02 1,739 10.21 0.2093
2024-10-09 2024-09-30 13F GILEAD SCIENCES COM 375558103 18,819 1,939 11.49 1,578 36.18 0.2008
2024-07-15 2024-06-30 13F GILEAD SCIENCES COM 375558103 16,880 -8,700 -34.01 1,158 -38.17 0.1693
2024-04-18 2024-03-31 13F GILEAD SCIENCES COM 375558103 25,580 9,223 56.39 1,874 41.36 0.3171
2024-01-16 2023-12-31 13F GILEAD SCIENCES COM 375558103 16,357 5,142 45.85 1,325 57.74 0.2482
2023-10-11 2023-09-30 13F GILEAD SCIENCES COM 375558103 11,215 5,675 102.44 840 97.18 0.1734
2023-07-14 2023-06-30 13F GILEAD SCIENCES COM 375558103 5,540 -396 -6.67 427 -13.41 0.0821
2023-05-03 2023-03-31 13F GILEAD SCIENCES COM 375558103 5,936 498 9.16 493 5.58 0.0963
2023-01-19 2022-12-31 13F GILEAD SCIENCES COM 375558103 5,438 -11 -0.20 467 38.69 0.0950
2022-10-14 2022-09-30 13F GILEAD SCIENCES COM 375558103 5,449 5 0.09 336 0.00 0.0751
2022-07-22 2022-06-30 13F GILEAD SCIENCES COM 375558103 5,444 -5 -0.09 336 3.70 0.0683
2022-05-02 2022-03-31 13F GILEAD SCIENCES COM 375558103 5,449 42 0.78 324 -17.56 0.0548
2022-01-26 2021-12-31 13F GILEAD SCIENCES COM 375558103 5,407 -903 -14.31 393 -10.88 0.0670
2021-11-02 2021-09-30 13F GILEAD SCIENCES COM 375558103 6,310 0 0.00 441 1.38 0.0760
2021-07-15 2021-06-30 13F GILEAD SCIENCES COM 375558103 6,310 -258 -3.93 435 2.59 0.0772
2021-04-19 2021-03-31 13F GILEAD SCIENCES COM 375558103 6,568 270 4.29 424 15.53 0.0814
2021-02-04 2020-12-31 13F GILEAD SCIENCES COM 375558103 6,298 -217 -3.33 367 -10.92 0.0736
2020-10-29 2020-09-30 13F GILEAD SCIENCES COM 375558103 6,515 1,996 44.17 412 18.39 0.0908
2020-08-11 2020-06-30 13F GILEAD SCIENCES COM 375558103 4,519 -302 -6.26 348 -3.33 0.0840
2020-04-23 2020-03-31 13F GILEAD SCIENCES COM 375558103 4,821 -696 -12.62 360 0.56 0.0958
2020-02-10 2019-12-31 13F GILEAD SCIENCES COM 375558103 5,517 0 0.00 358 2.29 0.0810
2019-10-22 2019-09-30 13F GILEAD SCIENCES COM 375558103 5,517 1,298 30.77 350 22.81 0.0867
2019-08-14 2019-06-30 13F GILEAD SCIENCES COM 375558103 4,219 4,219 285 0.0788
2017-08-10 2017-06-30 13F GILEAD SCIENCES COM 375558103 0 -32,320 -100.00 0 -100.00
2017-05-11 2017-03-31 13F GILEAD SCIENCES COM 375558103 32,320 1,773 5.80 2,195 0.37 0.7866
2017-02-10 2016-12-31 13F GILEAD SCIENCES COM 375558103 30,547 27,955 1,078.51 2,187 966.83 0.7643
2016-11-14 2016-09-30 13F GILEAD SCIENCES COM 375558103 2,592 173 7.15 205 1.49 0.0672
2016-08-11 2016-06-30 13F GILEAD SCIENCES COM 375558103 2,419 -1,053 -30.33 202 -36.68 0.0758
2016-05-11 2016-03-31 13F GILEAD SCIENCES COM 375558103 3,472 -382 -9.91 319 -18.21 0.1019
2016-02-16 2015-12-31 13F GILEAD SCIENCES COM 375558103 3,854 106 2.83 390 5.98 0.1527
2016-02-16 2015-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 3,748 781 26.32 368 6.05 0.1697
2015-11-13 2015-09-30 13F GILEAD SCIENCES COM 375558103 3,748 368
2015-08-13 2015-06-30 13F GILEAD SCIENCES COM 375558103 2,967 50 1.71 347 21.33 0.1477
2015-05-13 2015-03-31 13F GILEAD SCIENCES COM 375558103 2,917 211 7.80 286 12.16 0.1362
2015-02-17 2014-12-31 13F GILEAD SCIENCES COM 375558103 2,706 2,706 255 0.1405
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.